EMEA-001623-PIP03-20
Key facts
| Active substance |
Finerenone
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0243/2021
|
| PIP number |
EMEA-001623-PIP03-20
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of heart failure
|
| Route(s) of administration |
|
| Contact for public enquiries |
Bayer AG
Tel. +49 202364913 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|